ReportWire

Tag: WBA

  • Van ECK Associates Corp Grows Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

    Van ECK Associates Corp Grows Stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

    Van ECK Associates Corp boosted its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report) by 28.2% during the third quarter, HoldingsChannel.com reports. The fund owned 129,191 shares of the pharmacy operator’s stock after acquiring an additional 28,400 shares during the period. Van ECK Associates Corp’s holdings in Walgreens Boots Alliance were worth $2,873,000 as of its most recent filing with the Securities & Exchange Commission.

    Other large investors have also recently bought and sold shares of the company. BlackRock Inc. raised its holdings in shares of Walgreens Boots Alliance by 5.6% during the second quarter. BlackRock Inc. now owns 66,949,919 shares of the pharmacy operator’s stock valued at $1,907,403,000 after buying an additional 3,543,790 shares during the last quarter. Capital World Investors raised its holdings in shares of Walgreens Boots Alliance by 0.3% during the second quarter. Capital World Investors now owns 19,628,988 shares of the pharmacy operator’s stock valued at $559,230,000 after buying an additional 59,941 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Walgreens Boots Alliance by 17.7% during the second quarter. Geode Capital Management LLC now owns 15,807,842 shares of the pharmacy operator’s stock valued at $449,218,000 after buying an additional 2,373,357 shares during the last quarter. Morgan Stanley raised its holdings in shares of Walgreens Boots Alliance by 10.7% during the fourth quarter. Morgan Stanley now owns 11,974,220 shares of the pharmacy operator’s stock valued at $447,357,000 after buying an additional 1,155,331 shares during the last quarter. Finally, Moneta Group Investment Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 84,503.5% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 8,325,830 shares of the pharmacy operator’s stock valued at $311,053,000 after buying an additional 8,315,989 shares during the last quarter. Institutional investors own 57.92% of the company’s stock.

    Walgreens Boots Alliance Trading Down 4.8 %

    Walgreens Boots Alliance stock opened at $21.55 on Wednesday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.30 and a current ratio of 0.66. The firm has a market cap of $18.58 billion, a price-to-earnings ratio of 32.65, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. Walgreens Boots Alliance, Inc. has a 1 year low of $19.68 and a 1 year high of $37.13. The firm’s 50 day moving average price is $23.93 and its two-hundred day moving average price is $23.47.

    Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) last posted its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $0.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.62 by $0.04. The firm had revenue of $36.70 billion for the quarter, compared to analyst estimates of $34.95 billion. Walgreens Boots Alliance had a net margin of 0.40% and a return on equity of 10.48%. The firm’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.16 earnings per share. On average, research analysts predict that Walgreens Boots Alliance, Inc. will post 3.24 EPS for the current fiscal year.

    Walgreens Boots Alliance Cuts Dividend

    The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 12th. Shareholders of record on Tuesday, February 20th will be given a $0.25 dividend. The ex-dividend date of this dividend is Friday, February 16th. This represents a $1.00 annualized dividend and a yield of 4.64%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 290.91%.

    Insiders Place Their Bets

    In other news, Director Valerie B. Jarrett acquired 4,456 shares of the stock in a transaction on Monday, January 29th. The shares were purchased at an average cost of $22.44 per share, for a total transaction of $99,992.64. Following the transaction, the director now owns 4,456 shares in the company, valued at approximately $99,992.64. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. In other news, CEO Timothy C. Wentworth acquired 10,000 shares of the stock in a transaction on Friday, January 5th. The shares were purchased at an average cost of $24.22 per share, for a total transaction of $242,200.00. Following the transaction, the chief executive officer now owns 585,122 shares in the company, valued at approximately $14,171,654.84. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Valerie B. Jarrett acquired 4,456 shares of the stock in a transaction on Monday, January 29th. The shares were purchased at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the transaction, the director now owns 4,456 shares in the company, valued at approximately $99,992.64. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by company insiders.

    Wall Street Analyst Weigh In

    A number of equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. raised Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $27.00 to $30.00 in a report on Monday, October 23rd. TheStreet raised Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a report on Monday, January 8th. HSBC began coverage on Walgreens Boots Alliance in a report on Friday, December 22nd. They set a “hold” rating and a $27.00 target price on the stock. Finally, Barclays began coverage on Walgreens Boots Alliance in a report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 target price on the stock. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus target price of $28.25.

    Get Our Latest Stock Analysis on Walgreens Boots Alliance

    About Walgreens Boots Alliance

    (Free Report)

    Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

    See Also

    Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Free Report).

    Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

    Receive News & Ratings for Walgreens Boots Alliance Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Walgreens Boots Alliance and related companies with MarketBeat.com’s FREE daily email newsletter.

    ABMN Staff

    Source link

  • 7% Dividend Yields or Higher: The S&P 500’s 6 Best Payouts

    7% Dividend Yields or Higher: The S&P 500’s 6 Best Payouts

    7% Dividend Yields or Higher: The S&P 500’s 6 Best Payouts

    Source link

  • Ford, Microsoft, Delta, Walgreens, Birkenstock, and More Stock Market Movers

    Ford, Microsoft, Delta, Walgreens, Birkenstock, and More Stock Market Movers

    Stock futures posted modest gains Thursday ahead of a report likely to show that U.S. inflation fell in September as gasoline price growth slowed and used-car costs declined.

    [ad_2]
    Source link

  • Pharmacy Giant Walgreens Names Tim Wentworth as New CEO

    Pharmacy Giant Walgreens Names Tim Wentworth as New CEO

    Pharmacy Giant Walgreens Names Tim Wentworth as New CEO

    Source link

  • Blue Apron notches triple-digit percentage gain while Nike rallies after earnings beat and boosts Foot Locker stock

    Blue Apron notches triple-digit percentage gain while Nike rallies after earnings beat and boosts Foot Locker stock

    Here are the day’s biggest movers:

    Stock gainers:

    Blue Apron Holding Inc.’s stock
    APRN,
    +133.52%
    rocketed by 134% after food-delivery start-up Wonder said it would acquire the company for $13 a share or about $103 million, just a fraction of its $2 billion in 2017 when the company went public.

    Shares of Nike
    NKE,
    +5.96%
    rallied 7% as the apparel maker, which is also part of the Dow Jones Industrial Average
    DJIA,
    reported better-than-expected earnings, news that also lifted shares of European rivals including Adidas
    ADS,
    +6.22%    .

    Foot Locker
    FL,
    +2.71%    ,
    which sells athletic apparel, saw its stock rise by 3%.

    Walgreens Boots Alliance Inc.‘s stock
    WBA,
    +6.39%
    rose 6.2% as a top gainer among the Nasdaq 100
    NDX
    as stocks reacted with gains to the latest inflation data.

    Stock decliners:

    Bionomics 
    BNOX,
    -11.87%    ,
    whose shares jumped 242% on Thursday after reporting positive results from a mid-stage trial of a treatment for post-traumatic stress disorder, fell 8% in regular trade.

    Source link

  • Walgreens Is Looking for a New CEO. Why That Could Make the Stock a Winner.

    Walgreens Is Looking for a New CEO. Why That Could Make the Stock a Winner.

    Usually, the announcement of a CEO change at a struggling company brings optimism and maybe even a stock pop. Not for


    Walgreens Boots Alliance


    Its shares have tumbled since Rosalind Brewer announced on Sept. 1 that she was stepping down. That could present a buying opportunity if the company makes the “right” choice…

    Source link

  • Airbnb, Blackstone to join S&P 500, while Deere will replace Walgreens in S&P 100

    Airbnb, Blackstone to join S&P 500, while Deere will replace Walgreens in S&P 100

    Shares of investment giant Blackstone Inc. and vacation-home rental platform Airbnb Inc. rallied after hours on Friday after both won the nod to join the S&P 500 index
    SPX
    later this month.

    The announcement, from S&P Dow Jones Indices, said that the change would take hold before the start of trading on Monday, Sept. 18. The move, among others announced Friday, will “ensure each index is more representative of its market-capitalization range,” according to a release.

    Airbnb
    ABNB,
    +0.87%
    currently has a market value of $83.98 billion, and its shares are up 64.7% so far this year. Blackstone
    BX,
    -1.77%    ,
    currently worth $129.29 billion, has seen its stock rise 43.6% year-to-date.

    Shares of Airbnb and Blackstone were up 5.7% and 4.8%, respectively, after hours on Friday.

    Blackstone and Airbnb will replace Lincoln National Corp.
    LNC,
    +2.14%
    and Newell Brands Inc.
    NWL,
    +1.23%
    in the index, S&P Dow Jones Indices said on Friday. In the process, Lincoln and Newell will join the S&P SmallCap 600.

    Blackstone in July said it had reached $1 trillion in assets under management, aided by a growth trajectory that it said had outpaced its private equity rivals.

    “We’ve established an unparalleled global platform of leading business lines, offering over 70 distinct investment strategies,” Chief Executive Stephen Schwarzman told analysts. “We believe our clients view us as the gold standard in alternative asset management.”

    Meanwhile, Airbnb last month said that travelers were seeking longer stays and bigger properties in pricier areas, as the rebound in travel endures despite a tidal wave of inflation last year. The company’s second-quarter results and third-quarter sales forecast topped Wall Street’s estimates.

    Meanwhile, S&P 500 member Deere & Co.
    DE,
    +1.94%
    will replace Walgreens Boots Alliance Inc.
    WBA,
    -7.43%
    in the S&P 100, S&P Dow Jones Indices said on Friday. That change also takes hold on Sept. 18. S&P Dow Jones Indices said Walgreens “is no longer representative of the megacap market space” but will stay in the S&P 500.

    Shares of Deere fell 0.2% after hours. Walgreens stock was up 0.4%.

    Don’t miss: Walgreens CEO Roz Brewer steps down with stock at decade-and-a-half low

    Source link

  • Walgreens stock rallies after profit and sales beat expectations, helped by an acceleration of business in February

    Walgreens stock rallies after profit and sales beat expectations, helped by an acceleration of business in February

    Shares of Walgreens Boots Alliance Inc.
    WMB,
    +0.66%
    rallied 2.6% in premarket trading Tuesday, after the health care services and drug store chain reported fiscal second-quarter profit that beat expectations, but fell from a year ago due in part to lower COVID-19 testing and vaccinations. Net income for the quarter to Feb. 28 fell to $703 million, or 81 cents a share, from $883 million, or $1.02 a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share of $1.16 was above the FactSet consensus of $1.10. Sales grew 3.3% to $34.86 billion, well above the FactSet consensus $33.53 billion, boosted by an “acceleration” in February. U.S. Retail Pharmacy sales slipped 0.3% to $27.6 billion, but was above the FactSet consensus of $26.5 billion, while international increased 1.6% to $5.7 billion and U.S. Healthcare revenue more than doubled, to $1.6 billion from $500 million. Gross margin contracted to 20.2% from 22.8%, as cost of sale rose more than sales, up 6.8% to $27.81 billion. Looking ahead, the company affirmed its fiscal 2023 adjusted EPS guidance range of $4.45 to $4.65, which surrounds the FactSet consensus of $4.50. The stock has shed 11.8% year to date through Monday, while the Consumer Staple Select Sector SPDR exchange-traded fund
    XLP,
    +0.53%
    has eased 1.6% and the Dow Jones Industrial Average
    DJIA,
    +0.60%
    has slipped 2.2%.

    Source link

  • Lululemon, Intel, Carnival, Micron, Walgreens, and More Stocks to Watch This Week

    Lululemon, Intel, Carnival, Micron, Walgreens, and More Stocks to Watch This Week

    Data on the U.S. consumer and housing market, plus several notable earnings reports, will be this week’s highlights. Barring any surprises, federal financial regulators’ Congressional testimony will be the main event on the banking front.

    On Wednesday, Fed Vice Chair for Supervision Michael Barr and Federal Deposit Insurance Corp. Chairman Martin Gruenberg are scheduled to testify before the House Financial Services Committee. They’ll discuss the collapses of Silicon Valley Bank and Signature Bank and efforts to maintain confidence in the U.S. banking system.

    Source link

  • China predicts COVID ‘normalcy’ within months, but experts forecast more than 1 million deaths

    China predicts COVID ‘normalcy’ within months, but experts forecast more than 1 million deaths

    China’s closely watched reopening is now causing concern as the number of new COVID-19 cases grows and the country reports the first deaths in several weeks. 

    Much of the news out of China this week is in stark contrast to zero COVID, the strict policy that was in place up until a month ago. In response to widespread protests, authorities have lifted many of the restrictions that limited how people in China were able to move, work and treat their illnesses.

    Now some local governments are encouraging people with mild COVID to continue to work. Beijing reported five COVID deaths on Tuesday and two on Monday — the first COVID fatalities to be reported in the country in weeks. Cities like Guangzhou are expanding “fever clinics” that can handle up to 110,000 patients a day, up from 40,000. And basic cold medicines are in short supply.

    Chinese authorities have reportedly told state media that the surge is part of an “exit wave” of cases, according to the Financial Times. A headline from Monday’s China Daily, an English-language news outlet in China, reads: “Virus experts expect normalcy by spring.”

    Experts have predicted that millions of people in China will get sick, and up to 1.6 million people could die in 2023.

    COVID news to know: 

    • In the U.S., it’s still hard to find children’s cold medications. CVS Health
    CVS,
    -0.31%
    and Walgreens Boots Alliance
    WBA,
    +0.95%
    this week put limits on purchases of children’s cold and flu medicines in response to high demand amid a surge in cases of pediatric COVID, influenza and respiratory syncytial virus, or RSV, according to the Wall Street Journal. This includes medications like acetaminophen and ibuprofen. 

    • Testing positive a second or third time may worsen long-COVID symptoms, according to a study published in Nature in November. However, it can be hard to predict how each new infection will affect an individual patient. “It makes sense that repeat infections would not be beneficial to a person’s health,” one doctor told WebMD. “But I think it’s really hard to know what the additional risk of each subsequent infection would be because there are all sorts of other things in the mix.” 

    • COVID hospitalizations are rising in the U.S. There are about 40,000 people hospitalized with COVID right now, a figure that is 11% higher than it was two weeks ago, according to the most recent update of a New York Times tracker. The numbers of new infections and COVID-related deaths are also rising this month. The seven-day daily average of new cases is about 66,000, while about 413 people are dying each day.

    Source link

  • WBA Stock Price | Walgreens Boots Alliance Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch

    WBA Stock Price | Walgreens Boots Alliance Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch

    Walgreens Boots Alliance Inc.

    Walgreens Boots Alliance, Inc. engages in the provision of drug store services. It operates through the following segments: Retail Pharmacy USA and Retail Pharmacy International. The Retail Pharmacy USA segment consists of the Walgreens business, which includes the operation of retail drugstores, health and wellness services, and mail and central specialty pharmacy services. The Retail Pharmacy International segment consists of pharmacy-led health and beauty retail businesses and optical practices. The company was founded in 1901 and is headquartered in Deerfield, IL.

    Source link